Clinical Trial Update: FS222 First in Human Study in Patients With Advanced Malignancies [Phase 1]

View source ↗

Summary

First-in-human Phase 1 trial of FS222 in patients with advanced/metastatic cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• FS222

Snippet

Sponsor: invoX Pharma Limited | Conditions: Advanced Cancer, Metastatic Cancer | Phase 1 | Status: RECRUITING